Updates in the Treatment of Diffuse Large B-Cell Lymphoma


This article discusses the current treatment landscape and therapeutic strategies for relapse/refractory diffuse large B-cell lymphoma (R/R DLBCL), the role of CAR T-cell therapies in R/R DLBCL, and insights on new regimens and ongoing clinical trials from leading experts in hematologic malignancies.

Related Videos
Marin F. Xavier, MD
Christopher Flowers, MD
Related Content